A common feature of GBM has been identified by transcriptional analyses in the downregulation of TP53, RB1, and RTKs/Ras/PI3K pathways, recognizing these as fundamental requirements for the pathogenesis of GBM. This evidence concerns the gene RB1 and glioblastoma.